COLOMBO, Gaia
 Distribuzione geografica
Continente #
NA - Nord America 10.727
AS - Asia 6.197
EU - Europa 3.609
SA - Sud America 1.156
Continente sconosciuto - Info sul continente non disponibili 234
AF - Africa 148
OC - Oceania 33
Totale 22.104
Nazione #
US - Stati Uniti d'America 10.475
SG - Singapore 2.324
CN - Cina 1.495
IT - Italia 923
BR - Brasile 907
VN - Vietnam 624
UA - Ucraina 563
HK - Hong Kong 505
DE - Germania 389
TR - Turchia 331
FR - Francia 320
GB - Regno Unito 302
PL - Polonia 236
FI - Finlandia 218
BD - Bangladesh 216
SE - Svezia 172
JP - Giappone 157
RU - Federazione Russa 153
IN - India 142
CA - Canada 109
MX - Messico 102
ID - Indonesia 89
AR - Argentina 86
NL - Olanda 64
ZA - Sudafrica 59
ES - Italia 54
IQ - Iraq 50
PK - Pakistan 40
EC - Ecuador 36
CO - Colombia 33
GR - Grecia 31
CL - Cile 28
MY - Malesia 28
DK - Danimarca 26
IR - Iran 25
AU - Australia 24
VE - Venezuela 24
AT - Austria 22
BE - Belgio 22
CH - Svizzera 21
SA - Arabia Saudita 19
TN - Tunisia 19
IL - Israele 17
MA - Marocco 17
PE - Perù 16
UZ - Uzbekistan 16
PH - Filippine 15
PY - Paraguay 15
EG - Egitto 14
PT - Portogallo 13
AE - Emirati Arabi Uniti 12
LT - Lituania 11
BY - Bielorussia 10
IE - Irlanda 10
KR - Corea 10
RO - Romania 10
JO - Giordania 9
KE - Kenya 9
NZ - Nuova Zelanda 9
BO - Bolivia 8
CZ - Repubblica Ceca 8
BH - Bahrain 7
CR - Costa Rica 7
DZ - Algeria 7
NP - Nepal 6
TH - Thailandia 6
TW - Taiwan 6
AZ - Azerbaigian 5
BG - Bulgaria 5
GT - Guatemala 5
HU - Ungheria 5
JM - Giamaica 5
KZ - Kazakistan 5
LB - Libano 5
PA - Panama 5
PS - Palestinian Territory 5
GE - Georgia 4
KW - Kuwait 4
LV - Lettonia 4
AL - Albania 3
HR - Croazia 3
KG - Kirghizistan 3
ML - Mali 3
NG - Nigeria 3
OM - Oman 3
PR - Porto Rico 3
SY - Repubblica araba siriana 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
ET - Etiopia 2
EU - Europa 2
GA - Gabon 2
GD - Grenada 2
HN - Honduras 2
KH - Cambogia 2
LY - Libia 2
NI - Nicaragua 2
NO - Norvegia 2
RS - Serbia 2
Totale 21.838
Città #
Singapore 1.459
Ashburn 1.026
Fairfield 998
Woodbridge 957
Houston 701
Jacksonville 623
Santa Clara 579
Chandler 545
Hong Kong 478
Ann Arbor 472
San Jose 432
Beijing 408
Wilmington 371
Seattle 369
Cambridge 328
Izmir 243
Warsaw 224
Ho Chi Minh City 197
Nanjing 182
Council Bluffs 162
Princeton 153
Hanoi 147
Tokyo 144
Los Angeles 133
Lauterbourg 117
New York 107
Dallas 104
Boardman 100
Ferrara 100
Helsinki 94
San Diego 78
Shenyang 68
Milan 66
São Paulo 64
Mexico City 54
Nanchang 53
Rome 52
Hebei 44
Jakarta 44
Shanghai 44
Tianjin 44
London 40
Chicago 39
Atlanta 36
Haiphong 34
Mountain View 34
Redwood City 33
Da Nang 32
Rio de Janeiro 32
Hefei 31
Moscow 31
Bologna 30
Denver 29
Brooklyn 28
Falls Church 28
Frankfurt am Main 28
Jiaxing 28
Munich 28
Bremen 26
Addison 25
San Francisco 25
Toronto 25
Baghdad 23
Copenhagen 23
Buffalo 22
Johannesburg 22
Orem 22
Columbus 21
Poplar 21
Changsha 20
Phoenix 20
The Dalles 20
Brussels 19
Parma 19
Zhengzhou 18
Naples 17
Philadelphia 17
Boston 16
Brasília 16
Falkenstein 16
Jinan 16
Nuremberg 16
Santiago 16
Tashkent 16
Belo Horizonte 15
Norwalk 15
Orange 14
Guangzhou 13
Manchester 13
Montreal 13
Mumbai 13
Stockholm 13
Amsterdam 12
Auburn Hills 12
Des Moines 12
Fortaleza 12
Guayaquil 12
Hangzhou 12
Hải Dương 12
Lahore 12
Totale 13.827
Nome #
Studio di uno spray topico di sucralfato gel e cidofovir per la terapia antivirale di ovini 399
Opportunity and challenges of nasal powders: Drug formulation and delivery 392
PRINCIPI DI CALCOLO FARMACEUTICO 389
In vivo nose-to-brain delivery of the hydrophilic antiviral ribavirin by microparticle agglomerates 324
Biological In Vitro Models for Absorption by Nonoral Routes 287
Chimerical agglomerates of lecithin/chitosan nanoparticles for powder nasal delivery 275
The development of a single-use, capsule-free multi-breath tobramycin dry powder inhaler for the treatment of cystic fibrosis 265
Effect of residual water content on the physico-chemical properties of sucralfate dried gel obtained by microwave drying 245
Bioadhesive sucralfate gel-based suspension containing cidofovir for spray treatment of viral infections in lamb and sheep 234
Diclofenamic acid-vitamin C conjugates: stability and interaction studies with ascorbate transporters 227
Dry powder inhalers: An overview of the in vitro dissolution methodologies and their correlation with the biopharmaceutical aspects of the drug products 225
Surface-modified nanocarriers for nose-to-brain delivery: From bioadhesion to targeting 224
Respiratory Drug Delivery 221
Design of experiments (DoE) in pharmaceutical development 220
Assemblage of Novel Release Modules for the Development of Adaptable Drug Delivery Systems 212
Ex vivo permeation of tamoxifen and its 4-OH metabolite through rat intestine from lecithin/chitosan nanoparticles 212
Bioadhesive film for transdermal delivery of lidocaine: in vitro and in vivo behavior 211
Combinations of colistin solutions and nebulisers for lung infection management in cystic fibrosis patients 210
Nasal powders of thalidomide for local treatment of nose bleeding in persons affected by hereditary hemorrhagic telangiectasia 207
Brain Targeting of an Antiischemic Agent by Nasal Administration of Microparticles 206
Spray-dried amikacin sulphate powder for inhalation in cystic fibrosis patients: The role of ethanol in particle formation 199
Chitosan coated human serum albumin nanoparticles: A promising strategy for nose-to-brain drug delivery 190
Anti-inflammatory flurbiprofen nasal powders for nose-to-brain delivery in Alzheimer’s disease 188
Swellable and Rigid Matrices: Controlled Release Matrices with Cellulose Ethers 185
Artesunate-clindamycin multi-kinetics and site-specific oral delivery system for antimalaric combination products 185
The use of fatty acids as absorption enhancer for pulmonary drug delivery 184
Floating modular drug delivery systems with buoyancy independent of release mechanisms to sustain amoxicillin and clarithromycin intra-gastric concentrations 184
Dry powder inhalers of gentamicin and leucine: formulation parameters, aerosol performance and in vitro toxicity on CuFi1 cells 182
The Effect of Residual Water on Antacid Properties of Sucralfate Gel Dried by Microwaves 178
Bioencapsulation methods for cell inclusion in polysaccharidic matrices for clinical applications 177
Prolonged duration local anesthesia from tetrodotoxin-enhanced local anesthetic microspheres 177
Alginate and cell combination product for wound healing 175
N6-cyclopentyladenosine : selective brain targeting by nasal administration of microparticles 171
Skin permeation of 5-methoxypsoralen from topical dosage forms 170
Combination of alginate and cells for skin regeneration 166
Autoassembled nanoparticles of lecithin/chitosan for oral delivery of the anticancer drug tamoxifen citrate 166
Module assemblage technology for floating systems: in vitro flotation and in vivo gastro-retention 164
Prolonged duration local anesthesia with lipid-protein-sugar particles containing bupivacaine and dexamethasone 163
Flurbiprofen sodium microparticles and soft pellets for nose-to-brain delivery: Serum and brain levels in rats after nasal insufflation 163
Therapeutic paint of cidofovir/sucralfate gel combination topically administered by spraying for treatment of orf virus infections 161
The suitability of disintegrating force kinetics for studying the effect of manufacturing parameters on spironolactone tablet properties 161
Soft Agglomerates of Pantoprazole Gastro-resistant Microparticles for Oral Administration and Intestinal Release 160
A Study for the Development of Mesalazine Multiparticulate Dosage Forms for Colon Delivery in Pediatric Patients 159
Novel Platforms for Oral Drug Delivery 159
Ex vivo propofol permeation across nasal mucosa: A proof-of-concept study for outpatient light sedation via nasal route 157
A Clinical Study of a Methacholine Dry Powder for the Bronchial Challenge Test 157
The formulation of a novel macrolide solution pressurised metered dose inhaler: the use of Clarithromycin as an anti-inflammatory for bronchiectasis therapy 157
A new 5-methoxypsoralen formulation for the topical treatment of psoriasis 156
Nasal administration and brain targeting of an antiischemic agent 154
From tablets to pharmaceutical nanotechnologies: Innovation in drug delivery strategies for the administration of antimalarial drugs 154
Prolonged duration local anesthesia with lipid-protein-sugar particles containing bupivacaine and dexamethasone 151
Esomeprazole immediate release tablets: Gastric mucosa ex vivo permeation, absorption and antisecretory activity in conscious rats 151
Formulation Strategies for Antitubercular Drugs by Inhalation 150
Prolongation of sciatic nerve blockade by in situ cross-linked hyaluronic acid 149
In vitro and in vivo study of 5-methoxypsoralen skin concentration after topical application 149
Brain distribution of ribavirin after intranasal administration 149
Methacholine dry powder inhaler as a new tool for bronchial challenge test 148
Post-iontophoresis transport of ibuprofen lysine across rabbit ear skin 147
null 147
Aerosolization performance of jet nebulizers and biopharmaceutical aspects 146
Efficacy and biocompatibility of bupivacaine-loaded lipid-protein-sugar particles for prolonged duration local anesthesia 142
Preparation and Biophysical Characterization of Quercetin Inclusion Complexes with β-Cyclodextrin Derivatives to be Formulated as Possible Nose-to-Brain Quercetin Delivery Systems 142
Mechanisms of formation and disintegration of alginate beads obtained by prilling 141
Effect of excipient composition on the biocompatibility of bupivacaine-containing microparticles at the sciatic nerve 140
Geometric Release Systems: Principles, Release Mechanisms, Kinetics, Polymer Science, and Release-Modifying Material 136
Brain Uptake of an Antiischemic Agent by Nasal Administration of Microparticles 135
Single layer dermal patch: skin accumulation assessed by tape stripping 134
Aerodynamic assessment for inhalation products: fundamentals and current pharmacopoeial methods 133
Chitosan-coated nanoparticles: Effect of chitosan molecular weight on nasal transmucosal delivery 133
Rheological, thermal and spectroscopical properties of the macromolecular complex between sodium hyaluronate and cisplatin for anticancer chemotherapy 131
In vitro and in vivo study of a desmopressin nasal powder 130
Compositions in powder form made of soft agglomerates of a micronized drug and of a two-components excipient, and process for their preparation 130
Advanced Dome cellulose/alginate/chitosan composite matrix design with gastric and intestinal co-targeting capacities 129
Nasal powders of quercetin-β-cyclodextrin derivatives complexes with mannitol/lecithin microparticles for Nose-to-Brain delivery: In vitro and ex vivo evaluation 129
Antidiuretic effect of desmopressin chimera agglomerates by nasal administration in rats 128
PRODRUGS, MICRO OR NANOPARTICULATE SYSTEMS AND NASAL ADMNISTRATION AS NON INVASIVE APPROACHES AGAINST BRAIN DISEASES AND AIRBORNE INFECTIONS. LOCO-REGIONAL THERAPY OF CANCER 127
Dry powder inhaler of colistimethate sodium for lung infections in cystic fibrosis: optimization of powder construction 126
Strategies in bupivacaine delivery for prolonged duration local anesthesia 125
The role of dissolution test in a comparison of generic and branded controlled-release products 125
Comparative Serum and Brain Pharmacokinetics of Quercetin after Oral and Nasal Administration to Rats as Lyophilized Complexes with β-Cyclodextrin Derivatives and Their Blends with Mannitol/Lecithin Microparticles 123
null 122
Spray therapeutic paint for topical treatment of orf virus skin infections in breeding sheep 122
Therapeutic paint for simultaneous delivery of sucralfate gel and cidofovir in the treatment of veterinary viral skin infections 121
Nasal powders of morphine microcrystals agglomerates 121
Film for active ingredients dermal and transdermal administration 119
In vitro permeation of desmopressin across rabbit nasal mucosa from liquid nasal sprays: The enhancing effect of potassium sorbate 119
In vitro comparison of four anti-inflammatory topical medications 117
In vitro transport studies across excised nasal mucosa for three drug candidates to nose-to-brain delivery 116
Development of artemisinin - β-cyclodextrin complex agglomerates 115
Soft agglomerates containing microencapsulated levothyroxine for buccal or oral delivery 115
New modules, new assemblage kits and new assemblies for the controlled release of substances 114
Development of a spray-dried powder for nasal administration of desmopressin acetate 113
Multi-kinetics and site-specific release of gabapentin and flurbiprofen from oral fixed-dose combination: in vitro release and in vivo food effect 113
Soft chimera agglomerates for desmopressin nasal administration: an in vitro and in vivo study 112
Enhancing ribavirin nose-to-brain delivery by powder formulation for veterinary CNS infections 112
Assemblage of drug release modules: effect of module shape and position in the assembled systems on floating behavior and release rate 111
Orphan Designation and Cisplatin/Hyaluronan Complex in an Intracavitary Film for Malignant Mesothelioma 111
Progesterone-loaded lecithin/chitosan isopropylmyristate nanoparticles for transmucosal delivery 110
Produzione e caratterizzazione di nanoparticelle ottenute dall'interazione ionica tra lecitina e chitosano 109
Nose-to-brain delivery of ribavirin (RBV) for the treatment of viral encephalitis 109
Totale 16.714
Categoria #
all - tutte 93.409
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.757
Totale 98.166


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.265 51 154 98 66 55 76 44 76 41 101 118 385
2022/20231.299 164 54 27 159 238 193 34 127 167 15 86 35
2023/2024608 93 91 34 23 41 25 15 28 9 28 55 166
2024/20252.881 93 46 229 87 433 317 173 165 445 344 301 248
2025/20267.856 561 435 730 1.059 939 488 731 561 753 936 393 270
2026/2027412 412 0 0 0 0 0 0 0 0 0 0 0
Totale 22.104